These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15072701)

  • 1. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?
    Blakesley V; Awni W; Locke C; Ludden T; Granneman GR; Braverman LE
    Thyroid; 2004 Mar; 14(3):191-200. PubMed ID: 15072701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
    Blakesley VA
    AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence studies for levothyroxine.
    Bolton S
    AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.
    Benvenga S; Carlé A
    Adv Ther; 2019 Sep; 36(Suppl 2):59-71. PubMed ID: 31485974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.
    Colucci P; D'Angelo P; Mautone G; Scarsi C; Ducharme MP
    Ther Drug Monit; 2011 Jun; 33(3):355-61. PubMed ID: 21516059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of levothyroxine tablets administered to a target population in steady state.
    Cerutti R; Rivolta G; Cavalieri L; Di Giulio C; Grossi E; Vago T; Baldi G; Righini V; Marzo A
    Pharmacol Res; 1999 Mar; 39(3):193-201. PubMed ID: 10094844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
    Koytchev R; Lauschner R
    Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-T4 bioequivalence and hormone replacement studies via feedback control simulations.
    Eisenberg M; Samuels M; DiStefano JJ
    Thyroid; 2006 Dec; 16(12):1279-92. PubMed ID: 17199439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and pharmacokinetics of levothyroxine suppository in patients with hypothyroidism.
    Kashiwagura Y; Uchida S; Tanaka S; Watanabe H; Masuzawa M; Sasaki T; Namiki N
    Biol Pharm Bull; 2014; 37(4):666-70. PubMed ID: 24694613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study in normal human volunteers to compare the rate and extent of levothyroxine absorption from Synthroid and Levoxine.
    Berg JA; Mayor GH
    J Clin Pharmacol; 1992 Dec; 32(12):1135-40. PubMed ID: 1487553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of Levothyroxine Bioequivalence Evaluation: Analysis of An Attempted Study.
    Mayor GH; Orlando T; Kurtz NM
    Am J Ther; 1995 Jun; 2(6):417-432. PubMed ID: 11850687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroxine and treatment of hypothyroidism: seven decades of experience.
    Mateo RCI; Hennessey JV
    Endocrine; 2019 Oct; 66(1):10-17. PubMed ID: 31321670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat?
    Nagy EV; Perros P; Papini E; Katko M; Hegedüs L
    Thyroid; 2021 Feb; 31(2):193-201. PubMed ID: 33003978
    [No Abstract]   [Full Text] [Related]  

  • 17. Levothyroxine dosage and the limitations of current bioequivalence standards.
    Hennessey JV
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence.
    Wartofsky L
    Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Does Not Suppress Serum Thyrotropin by Increasing Levothyroxine Absorption.
    Al-Alusi MA; Du L; Li N; Yeh MW; He X; Braverman LE; Leung AM
    Thyroid; 2015 Oct; 25(10):1080-4. PubMed ID: 26191653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.